Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Precision Biosciences Inc's Business Segments
Precision Biosciences Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Operating
Total Revenue
$ 11
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Operating100%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Operating | $ 11 | 100% |
Description of Precision Biosciences Inc
Precision Biosciences Inc. is a biotechnology company that specializes in the development and application of its proprietary genome editing platform called ARCUS. The company was founded in 2006 and is headquartered in North Carolina, United States.
Precision Biosciences' ARCUS technology is based on a natural DNA-cutting enzyme called I-CreI. This enzyme has been engineered to create a highly specific and efficient genome editing tool known as a homing endonuclease. By utilizing the advantages of this technology, Precision Biosciences aims to address various genetic diseases, develop new therapeutics, and improve agricultural and industrial processes.
One of the key features of Precision Biosciences' genome editing platform is its high precision. The ARCUS technology has been designed to precisely edit target genes without causing extensive off-target effects, reducing the potential for unintended consequences. This precision allows for more efficient and reliable gene editing, which is crucial for the successful development of new therapies and treatments.
Precision Biosciences has established collaborations and partnerships with leading organizations in the biomedical and agricultural sectors. These collaborations enable the company to leverage its ARCUS technology across various applications, such as gene therapies, immuno-oncology, and agriculture.
In the field of gene therapy, Precision Biosciences is utilizing its ARCUS technology to develop innovative treatments for genetic diseases. The company aims to correct or remove disease-causing mutations in patient cells, potentially offering potential cures for previously incurable conditions.
Precision Biosciences also focuses on immuno-oncology, where it develops next-generation CAR T-cell therapies. By editing immune cells to enhance their ability to recognize and kill cancer cells, Precision Biosciences aims to improve the effectiveness and safety of immunotherapies for cancer treatment.
In addition to human health applications, Precision Biosciences is actively involved in agricultural biotechnology. The company works on enhancing crop traits, such as yield, drought resistance, and nutritional content, using its ARCUS platform. This could lead to the development of more sustainable and efficient agricultural practices.
Overall, Precision Biosciences Inc. is a renowned biotechnology company that utilizes its proprietary ARCUS technology to drive advancements in genome editing for various applications. The company's focus on precision, partnerships, and diverse applications positions it as a leader in the field, with the potential to make significant contributions to human health and agriculture.
Precision Biosciences' ARCUS technology is based on a natural DNA-cutting enzyme called I-CreI. This enzyme has been engineered to create a highly specific and efficient genome editing tool known as a homing endonuclease. By utilizing the advantages of this technology, Precision Biosciences aims to address various genetic diseases, develop new therapeutics, and improve agricultural and industrial processes.
One of the key features of Precision Biosciences' genome editing platform is its high precision. The ARCUS technology has been designed to precisely edit target genes without causing extensive off-target effects, reducing the potential for unintended consequences. This precision allows for more efficient and reliable gene editing, which is crucial for the successful development of new therapies and treatments.
Precision Biosciences has established collaborations and partnerships with leading organizations in the biomedical and agricultural sectors. These collaborations enable the company to leverage its ARCUS technology across various applications, such as gene therapies, immuno-oncology, and agriculture.
In the field of gene therapy, Precision Biosciences is utilizing its ARCUS technology to develop innovative treatments for genetic diseases. The company aims to correct or remove disease-causing mutations in patient cells, potentially offering potential cures for previously incurable conditions.
Precision Biosciences also focuses on immuno-oncology, where it develops next-generation CAR T-cell therapies. By editing immune cells to enhance their ability to recognize and kill cancer cells, Precision Biosciences aims to improve the effectiveness and safety of immunotherapies for cancer treatment.
In addition to human health applications, Precision Biosciences is actively involved in agricultural biotechnology. The company works on enhancing crop traits, such as yield, drought resistance, and nutritional content, using its ARCUS platform. This could lead to the development of more sustainable and efficient agricultural practices.
Overall, Precision Biosciences Inc. is a renowned biotechnology company that utilizes its proprietary ARCUS technology to drive advancements in genome editing for various applications. The company's focus on precision, partnerships, and diverse applications positions it as a leader in the field, with the potential to make significant contributions to human health and agriculture.
Precision Biosciences Inc. is a pioneering biotechnology company that specializes in genome editing technologies, primarily through its proprietary ARCUS platform. The company operates across three main segments: Therapeutics, Food and Agriculture, and Emerging Applications, each of which contributes to addressing critical challenges across various industries.
1. Therapeutics
Core Offerings:
Precision Biosciences is at the forefront of therapeutics innovation, particularly in harnessing genome editing to develop advanced gene therapies. Their ARCUS genome editing platform is central to their offerings, allowing for precise and targeted genetic modifications with high specificity. This technology enables the creation of customized therapies tailored to individual patient needs, which is particularly crucial in treating complex diseases.
Key Areas of Focus:
- Genetic Disorders: The company is leveraging its technologies to develop treatments for a range of genetic disorders, offering potential cures through the correction of faulty genes.
- Cancer Therapeutics: Precision Biosciences collaborates with pharmaceutical companies to design novel cancer therapies that utilize gene-editing to target and alter the genetic components of cancer cells, thereby improving treatment efficacy.
- Infectious Diseases: The ongoing threat of infectious diseases drives the need for innovative treatments, and Precisions capabilities in genome editing provide avenues for developing novel antiviral therapies.
Collaborative Efforts:
Precision engages in partnerships with drug developers, academic institutions, and clinical trial organizations, which enhances their capacity to cultivate and validate new therapeutic modalities across these disease areas.
Food and Agriculture
Strategic Goals:
Recognizing the pressing need for sustainable food systems, Precision Biosciences applies its genome editing expertise to enhance crop performance and quality. This commitment positions the company as a critical player in the agricultural biotechnology landscape.
Innovative Developments:
- Disease Resistance: Through precision genome editing, the company develops crops that possess enhanced resistance to pathogens, reducing the reliance on chemical pesticides and promoting healthier ecosystems.
- Drought Tolerance: With climate change posing significant risks to agriculture, Precision Biosciences focuses on engineering crops capable of withstanding prolonged drought conditions, thereby ensuring food security in arid regions.
- Nutritional Enhancements: The company is also invested in improving the nutritional profile of various crops, which can help address malnutrition and contribute to better health outcomes globally.
Collaborations:
Precision partners with agricultural organizations and biotechnology firms, integrating their technologies into new crop varieties that address both environmental challenges and consumer needs.
Emerging Applications
Exploratory Ventures:
In addition to its primary focus areas, Precision Biosciences is actively exploring the potential of genome editing in other innovative sectors. This includes applications where their expertise can be transformative.
Potential Fields of Application:
- Industrial Biotechnology: The company seeks to enhance the production of biofuels, bioplastics, and other materials through genome-edited microorganisms, facilitating more sustainable manufacturing practices.
- Renewable Energy: Precision is investigating how genome editing can be utilized to optimize cellulose production for bioenergy, thereby playing a role in the transition to renewable energy sources.
- Environmental Conservation: The company also aims to develop solutions that address environmental degradation, such as engineered organisms that can bio-remediate contaminated environments.
Collaborative Strategies:
By engaging with diverse industries, Precision Biosciences seeks to push the boundaries of genome editing, driving innovation and practical applications that can lead to significant societal benefits.
Conclusion
Precision Biosciences Inc. stands out as a visionary company within the biotechnology sector, with a diversified portfolio that spans therapeutics, food and agriculture, and emerging applications of genome editing technologies. Their innovative ARCUS platform serves as a catalyst for advancements across these critical fields, underscoring the companys integral role in addressing global challenges and improving outcomes for individuals and communities alike.
1. Therapeutics
Core Offerings:
Precision Biosciences is at the forefront of therapeutics innovation, particularly in harnessing genome editing to develop advanced gene therapies. Their ARCUS genome editing platform is central to their offerings, allowing for precise and targeted genetic modifications with high specificity. This technology enables the creation of customized therapies tailored to individual patient needs, which is particularly crucial in treating complex diseases.
Key Areas of Focus:
- Genetic Disorders: The company is leveraging its technologies to develop treatments for a range of genetic disorders, offering potential cures through the correction of faulty genes.
- Cancer Therapeutics: Precision Biosciences collaborates with pharmaceutical companies to design novel cancer therapies that utilize gene-editing to target and alter the genetic components of cancer cells, thereby improving treatment efficacy.
- Infectious Diseases: The ongoing threat of infectious diseases drives the need for innovative treatments, and Precisions capabilities in genome editing provide avenues for developing novel antiviral therapies.
Collaborative Efforts:
Precision engages in partnerships with drug developers, academic institutions, and clinical trial organizations, which enhances their capacity to cultivate and validate new therapeutic modalities across these disease areas.
Food and Agriculture
Strategic Goals:
Recognizing the pressing need for sustainable food systems, Precision Biosciences applies its genome editing expertise to enhance crop performance and quality. This commitment positions the company as a critical player in the agricultural biotechnology landscape.
Innovative Developments:
- Disease Resistance: Through precision genome editing, the company develops crops that possess enhanced resistance to pathogens, reducing the reliance on chemical pesticides and promoting healthier ecosystems.
- Drought Tolerance: With climate change posing significant risks to agriculture, Precision Biosciences focuses on engineering crops capable of withstanding prolonged drought conditions, thereby ensuring food security in arid regions.
- Nutritional Enhancements: The company is also invested in improving the nutritional profile of various crops, which can help address malnutrition and contribute to better health outcomes globally.
Collaborations:
Precision partners with agricultural organizations and biotechnology firms, integrating their technologies into new crop varieties that address both environmental challenges and consumer needs.
Emerging Applications
Exploratory Ventures:
In addition to its primary focus areas, Precision Biosciences is actively exploring the potential of genome editing in other innovative sectors. This includes applications where their expertise can be transformative.
Potential Fields of Application:
- Industrial Biotechnology: The company seeks to enhance the production of biofuels, bioplastics, and other materials through genome-edited microorganisms, facilitating more sustainable manufacturing practices.
- Renewable Energy: Precision is investigating how genome editing can be utilized to optimize cellulose production for bioenergy, thereby playing a role in the transition to renewable energy sources.
- Environmental Conservation: The company also aims to develop solutions that address environmental degradation, such as engineered organisms that can bio-remediate contaminated environments.
Collaborative Strategies:
By engaging with diverse industries, Precision Biosciences seeks to push the boundaries of genome editing, driving innovation and practical applications that can lead to significant societal benefits.
Conclusion
Precision Biosciences Inc. stands out as a visionary company within the biotechnology sector, with a diversified portfolio that spans therapeutics, food and agriculture, and emerging applications of genome editing technologies. Their innovative ARCUS platform serves as a catalyst for advancements across these critical fields, underscoring the companys integral role in addressing global challenges and improving outcomes for individuals and communities alike.